WebinarsCORNERSTONE technology for purification of clinical-quality AAV
To listen to audio podcast online click here. ...
To listen to audio podcast online click here. ...
Messenger RNA is poised to become a major contributor in the fields of gene therapy and vaccines. Making this a practical reality requires purification technology that accommodates its unique features ...
Presenter: Aleš Štrancar Event: BPI and Cell & Gene Therapy Bioprocessing & Commercialization 2021 Date: September 28, 2021 Abstract: Adeno associated virus (AAV) is the leading vector i ...
Presenter: Aleš Štrancar Date: October 27, 2020 Gene Therapy for Rare Disorders Europe 2020 (digital event) Bullet points: Buffer optimisation and proper column ligand selection (CIM ...
Event: Nucleic Acids- cGMP Production of mRNA & pDNA (virtual edition) Date: February 1, 2021 Our new Head of Process Development for mRNA and pDNA purification, Rok Sekirnik, presented our Chro ...
Presenter: Aleš Štrancar Event: ASGCT 24th Annual Meeting Date: May 13, 2021 Abstract Adeno associated virus (AAV) is the leading vector in the field of gene therapy because of its low t ...
Presenter: Ivana Petrović Koshmak Event: 2nd Annual Gene Therapy Analytical Development EU Date: May 26, 2021 Abstract: In-process analytics of vector capsid production is a critical opt ...
Published: Cell & Gene Therapy Insights 2021; 7(12), 1661 Date: December 20, 2021 Presenter: Maja Leskovec, Head of Process Development Viruses (viral vectors and vaccines) Watch the video or ...
Speaker: Mojca Tajnik Sbaizero, Project Manager rAAV downstream process using monoliths contains a series of steps that are mutually dependent. Therefore each step should be optimized for suffic ...
Event: Cell and Gene Therapy Insights webinar Date: March 1, 2023 Presenter: Blaž Bakalar, Product Manager PATfix platform mRNA-based therapeutics represent a promising new modality for ther ...